Roche and Exiqon are offering assays for discovering the functionality of targets in complex biological pathways and research their influence on processes leading to diseases or disorders.
The companies are offering Roche's Real Time ready assays and Exiqon's Mircury LNA Universal RT microRNA qPCR system.
A bundle of measures such as webinars, seminars and linked internet appearances are planned to promote the joint offer.
With Roche's Real Time ready assays, targets of choice are selectable from gene lists of functionally related gene families or biological pathways.
They can be ordered as single assays or configured as a custom panel on a Lightcycler 480 Multiwell Plate.
The function-tested qPCR assays based on the Universal Probe Library technology offer detailed bioinformatics background information and novel error-detection features.
Exiqon's Mircury LNA Universal RT microRNA PCR system offers solutions for the microRNA real-time PCR market.
The use of LNA-enhanced PCR primers secures high sensitivity and specificity, enabling accurate quantification of very low amounts of microRNA obtained from difficult samples such as FFPE, serum/plasma and laser-capture microscopy.
The product line, which includes reagents for the Lightcycler 480 System, consists of microRNA ready-to-use PCR panels for expression profiling of human and rodent microRNAs, individual microRNA assays, reference genes and reagent kits.
